Michael M-c Lo

Title: Michael M-c Lo: Innovator in Bombesin Receptor Modulation

Introduction

Michael M-c Lo is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmacology, particularly through his innovative work on bombesin receptor modulators. His research focuses on developing novel compounds that can aid in the treatment of various diseases.

Latest Patents

Michael M-c Lo holds a patent for "Substituted imidazoles as bombesin receptor subtype-3 modulators." This patent describes certain novel substituted imidazoles that act as ligands for the human bombesin receptor, specifically targeting the bombesin receptor subtype-3 (BRS-3). These compounds are particularly useful for addressing conditions such as obesity and diabetes, which are responsive to BRS-3 modulation. He has 1 patent to his name.

Career Highlights

Throughout his career, Michael has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Albany Molecular Research, Inc. His work in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Michael has collaborated with esteemed colleagues, including David Chen and Christopher L Franklin. These partnerships have fostered a productive environment for innovation and research in the field of pharmacology.

Conclusion

Michael M-c Lo's contributions to the development of bombesin receptor modulators highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new treatments for obesity and diabetes.